Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Incyte Corporation (INCY)

« Back to company index

INCY Chatter Timeline

Stock Ticker for INCY

Most Active Tweeters for INCY

UserTweets
@Gambiste1 19
@Tickeron 15
@sleekoptions 14
@AmericanBanking 10
@DataTrials 10

Recent Tweets for INCY

Gambiste1 @Gambiste1
RT @weygand_gmt: #Incyte Targets: 88,83 and 96,44 USD $INCY #Biotech #Aktien #Equities https://t.co/JDafjsfyU9
November 10th 2019, 6:11pm
weygand_gmt @weygand_gmt
#Incyte Targets: 88,83 and 96,44 USD $INCY #Biotech #Aktien #Equities https://t.co/JDafjsfyU9
November 10th 2019, 4:11pm
Gambiste1 @Gambiste1
RT @BayAreaBiotechI: $INCY was an aberration, does that mean $NKTR is? #SITC19 https://t.co/hWuugFKEIM
November 10th 2019, 11:11am
Gambiste1 @Gambiste1
RT @KayatekinCan: Reminder of the $INCY IDO data. $NKTR seems to have deeper responses fwiw. https://t.co/ft4Lvo8t43
November 10th 2019, 8:11am
StockTipRobot @StockTipRobot
Buy! Sell! No buy! On second thought, sell! Actually just stop buying Incyte $INCY #money
November 10th 2019, 8:11am
Tickeron @Tickeron
$INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators:… https://t.co/2sPiAaYtSq
November 10th 2019, 8:11am
KayatekinCan @KayatekinCan
Reminder of the $INCY IDO data. $NKTR seems to have deeper responses fwiw. https://t.co/ft4Lvo8t43
November 10th 2019, 8:11am
Hall8Jack @Hall8Jack
RT @edtaussig: $NKTR $INCY https://t.co/oidSO66afi "Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combi…
November 10th 2019, 7:11am
WatchlistN @WatchlistN
Incyte Co. $INCY Director Wendy L. Dixon Sells 10,576 Shares https://t.co/4Fb0xYXj8U
November 10th 2019, 6:11am
TranscriptDaily @TranscriptDaily
Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/2n0CeLrqKV
November 10th 2019, 5:11am
EnterpriseLeade @EnterpriseLeade
Incyte Co. $INCY Director Wendy L. Dixon Sells 41,218 Shares https://t.co/qKYq6H43Ad
November 10th 2019, 5:11am
edtaussig @edtaussig
$NKTR $INCY https://t.co/oidSO66afi "Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination"
November 10th 2019, 2:11am
BayAreaBiotechI @BayAreaBiotechI
$INCY was an aberration, does that mean $NKTR is? #SITC19 https://t.co/hWuugFKEIM
November 10th 2019, 12:11am
Gambiste1 @Gambiste1
RT @thestaghound: @Dr_Aggen This is awful $INCY
November 9th 2019, 11:11pm
thestaghound @thestaghound
@Dr_Aggen This is awful $INCY
November 9th 2019, 11:11pm
Miljenkoz @Miljenkoz
@AndyBiotech Andy, with that comparison you tunked more than REGULAR BULLSHITER! $NKTR $INCY
November 9th 2019, 8:11pm
Gambiste1 @Gambiste1
RT @gcassidy718: $INCY this is the time you buy equities thank you fed 2.83 % change recently https://t.co/n8cAMFdPkt
November 9th 2019, 8:11pm
gcassidy718 @gcassidy718
$INCY this is the time you buy equities thank you fed 2.83 % change recently https://t.co/n8cAMFdPkt
November 9th 2019, 7:11pm
Tickeron @Tickeron
$INCY in Uptrend: RSI indicator enters overbought zone. View odds for this and other indicators:… https://t.co/9cMquJIYfm
November 9th 2019, 9:11am
ZolmaxNews @ZolmaxNews
Insider Selling: Incyte Co. $INCY Director Sells 41,218 Shares of Stock https://t.co/l2Io34qMGr
November 9th 2019, 8:11am
dailypoliticaln @dailypoliticaln
Incyte Co. $INCY Director Wendy L. Dixon Sells 41,218 Shares of Stock https://t.co/YkJ5I5sjGS
November 9th 2019, 8:11am
MonitorAction @MonitorAction
$INCY Wendy Dixon sells $3.5M Worth Of Incyte Stock https://t.co/tRadk7lSjv
November 8th 2019, 10:11pm
AmericanBanking @AmericanBanking
Insider Selling: Incyte Co. $INCY Director Sells 10,576 Shares of Stock https://t.co/jg1EeSsNZt #stocks
November 8th 2019, 7:11pm
AmericanBanking @AmericanBanking
Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/6YkpkRmeji #stocks
November 8th 2019, 7:11pm
ConsumerFeed @ConsumerFeed
Wendy L. Dixon Sells 41,218 Shares of Incyte Co. $INCY Stock https://t.co/lB6PsNHp4v
November 8th 2019, 7:11pm
InsiderAlertsIA @InsiderAlertsIA
$INCY: New Insider Filing on Director WENDY L DIXON: https://t.co/3m8IEaGzA5
November 8th 2019, 5:11pm
RTFilingsStocks @RTFilingsStocks
DIXON WENDY L files Form 4 for $INCY Sold 53334 shares Price range: $83.6-84.16 Transaction Dates: 11/6/2019-11/8/2… https://t.co/KIDshrYpYL
November 8th 2019, 5:11pm
ActionTrading1 @ActionTrading1
$INCY 4 Hours https://t.co/Qe68CjCtHm
November 8th 2019, 4:11pm
ActionTrading1 @ActionTrading1
$INCY Hourly https://t.co/LjSKMjfROV
November 8th 2019, 4:11pm
Tickeron @Tickeron
$INCY in Uptrend: Stochastic indicator stays in overbought zone for 6 days. View odds for this and other indicators… https://t.co/xbLv7vI7AL
November 8th 2019, 12:11pm
Wolfmetric @Wolfmetric
$INCY strong red-to-green move today
November 8th 2019, 11:11am
ActionTrading1 @ActionTrading1
$INCY Hourly https://t.co/9Nq6Dctni6
November 8th 2019, 7:11am
ActionTrading1 @ActionTrading1
$INCY 4 Hours https://t.co/X8v2ha141D
November 8th 2019, 7:11am
bbnsnews @bbnsnews
Incyte Co. $INCY Insider Paul Trower Sells 8,500 Shares https://t.co/efobeRcB9F
November 8th 2019, 5:11am
WeekHerald @WeekHerald
Incyte Co. $INCY Insider Sells $722,500.00 in Stock https://t.co/sJtQ25szw9
November 8th 2019, 5:11am
sleekoptions @sleekoptions
$INCY Was up 1.11 %. Turned negative -1.10 % | (Green to red move) https://t.co/ksN8HlN6pO https://t.co/GczHogVYAB
November 7th 2019, 9:11pm
sleekoptions @sleekoptions
$INCY Was up 1.11 %. Turned negative -0.82 % | (Green to red move) https://t.co/ksN8HlN6pO https://t.co/F12iyLekAe
November 7th 2019, 2:11pm
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $INCY? The Short Ratio is 4.77% https://t.co/oNwLaFBWtL
November 7th 2019, 2:11pm
AlertTrade @AlertTrade
TREND REVERSAL DOWN ALERT: $INCY Incyte Corporation Common Stock ? TradeIdeas via https://t.co/VS8RO1bzXJ to FREE Trading Room
November 7th 2019, 1:11pm
StockTexts @StockTexts
$INCY Incyte Corporation SEC Filing: Form CT ORDER https://t.co/yNNicH45cR
November 7th 2019, 1:11pm
Stock_News_Now @Stock_News_Now
$INCY: New SEC Filing for INCY: Form CT ORDER (No. 9999999997-19-007466): https://t.co/CnVjdLAAPI
November 7th 2019, 1:11pm
ProTradersNews @ProTradersNews
$INCY: Here’s Why Incyte Corporation Jumped 13.0% in October: https://t.co/z7W8RtbU1l
November 7th 2019, 12:11pm
Tickeron @Tickeron
$INCY in Downtrend: 50-day Moving Average broke below 200-day Moving Average on October 4, 2019. View odds for this… https://t.co/CyUHgD7UA0
November 7th 2019, 8:11am
Gambiste1 @Gambiste1
RT @DataTrials: $INCY Phase 1 Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies…NCT01905813. Estimated Primary Co…
November 7th 2019, 7:11am
Gambiste1 @Gambiste1
RT @DataTrials: $INCY Phase 1|Phase 2 A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refract…
November 7th 2019, 7:11am
Gambiste1 @Gambiste1
RT @DataTrials: $INCY Phase 1|Phase 2 A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib…
November 7th 2019, 7:11am
Gambiste1 @Gambiste1
RT @DataTrials: $INCY Phase 1|Phase 2 A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib…NCT01…
November 7th 2019, 7:11am
Gambiste1 @Gambiste1
RT @DataTrials: $INCY Phase 2 A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma…
November 7th 2019, 7:11am
Gambiste1 @Gambiste1
RT @DataTrials: $INCY Phase 2 A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cel…
November 7th 2019, 7:11am
Gambiste1 @Gambiste1
RT @DataTrials: $INCY Phase 1 INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previ…
November 7th 2019, 7:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.